myirislogo
20 December, 2014 10:37 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 304.25 0.73
Hindalco In 157.65 2.64
Infosys 2001.90 1.81
Icici Bank 355.40 2.95
Tata Stl 405.20 2.99
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Medicamen Biotech Limited
Medicamen Biotech Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:531146NSE:NABloomberg:MDCB@INReuters:MEBI.BO
Market Lot: 1Face Value: 10ISIN Demat: INE646B01010
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
30-MAY-13 Medicamen Biotech announced that its board of directors appointed Jitendra Nath Ojha as additional director & further appointed him as whole-time director w.e.f. May 30, 2013. 12-DEC-11 Medicamen Biotech has announced that the Company gets Anvisa Brazil approval for Non Beta Lactum solid tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi, Rajasthan vide Resolution 5397 No RE of Dec. 02, 2...   More..
Business Profile Future Plans
One To One
Recent news
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 190.22732.49639.98
Other Income4.466.067.32
Total Income194.68738.55647.30
Cost of goods sold181.54691.71654.24
OPBDIT13.1446.84-6.94
PAT3.040.94-49.28
Gross Block---
Equity capital89.1489.1484.90
EPS (Rs.)-0.11-5.88
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-43.18 - 109.00NA
Debt / Equity (x)---
Operating margin (% of OI) 6.7 6.3-1.1
Net margin (% of OI) 1.6 0.1-7.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
10, Community Centre No 2
Ashok Vihar
Phase-II
Delhi
Delhi-110 052
PHONE
(011) 2746 3506
FAX
(011) 2713 8171
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer